井上 晃男 先生のプロフィール

井上 晃男 先生

いのうえ てるお

井上 晃男 先生

獨協医科大学内科学(心臓・血管) 教授

井上 晃男 先生のストーリー記事を読む

専門分野

循環器内科学

紹介

循環器内科医。動脈硬化の発症や進展、プラーク破綻などの血管の様々な病態を統合した「血管不全」と呼ばれる新概念を提唱。血管不全の病態の解明に向け日夜研究に励んでいる。研究者としての顔だけでなく、教育者としても志高く優秀な循環器内科医を育成し、輩出してきた。「患者さんに幸せになってもらう医療の実現」のために、患者さんやご家族、後進の医師、スタッフなどに真摯に向き合っている。

略歴

1981年 信州大学医学部卒業
1981年 日本赤十字社医療センター 研修医
1983年 日本赤十字社医療センター 医員
1984年 獨協医科大学越谷病院循環器内科 助手
1991年 獨協医科大学越谷病院循環器内科 講師
2004年 佐賀大学医学部循環器内科 准教授
2009年 獨協医科大学心臓・血管内科教授

所属学会・資格・役職など

医学博士
日本内科学会 認定医
日本内科学会関東地方会 評議員
日本循環器学会 専門医・代議員
日本循環器学会関東甲信越地方会 評議員・支部役員
日本心臓病学会 FJCC・評議員
日本冠疾患学会 FJCS・評議員
日本脈管学会 評議員
日本臨床生理学会 理事
日本血管不全学会 理事
米国心臓病学会 FACC

受賞・著書・論文など

【受賞】
American Heart Association: Percutaneous Coronary Intervention Award 2002年
Circulation: Best Paper Award (Translational Science) 2007年

【論文】
1 Inoue T, Morooka S, Hayashi T, Takayanagi K, Sakai Y, Yamanaka T, Yamaguchi H, Shimizu M, Fujimura H, Kakoi H, Satoh T, Takabatake Y. Effectiveness of continuous arteriovenous hemofiltration for patients with refractory heart failure. Jpn Heart J 1988; 29: 595-602
2 Inoue T, Yamaguchi H, Hayashi T, Morooka S, Takabatake Y. Right-to-left shunting through a patent foramen ovale caused by pulmonary hypertention associated with rheumatoid arthrit

【受賞】
American Heart Association: Percutaneous Coronary Intervention Award 2002年
Circulation: Best Paper Award (Translational Science) 2007年

【論文】
1 Inoue T, Morooka S, Hayashi T, Takayanagi K, Sakai Y, Yamanaka T, Yamaguchi H, Shimizu M, Fujimura H, Kakoi H, Satoh T, Takabatake Y. Effectiveness of continuous arteriovenous hemofiltration for patients with refractory heart failure. Jpn Heart J 1988; 29: 595-602
2 Inoue T, Yamaguchi H, Hayashi T, Morooka S, Takabatake Y. Right-to-left shunting through a patent foramen ovale caused by pulmonary hypertention associated with rheumatoid arthritis and Sjogren's syndrome: a case report. Angiology 1990; 41: 1082-1085
3 Inoue T, Morooka S, Hayashi T, Takayanagi K, Sakai Y, Fujito T, Fujinuma S, Takabatake Y. Global and regional abnormalities of left ventricular diastolic filling in hypertrophic cardiomyopathy. Clin Cardiol 1991; 14: 573-577
4 Inoue T, Morooka S, Hayashi T, Takayanagi K, Sakai Y, Takabatake Y. Left ventricular diastolic filling in patients with coronary artery disease without myocardial infarction. Clin Cardiol 1991; 14: 657-664
5 Inoue T, Morooka S, Hayashi T, Takayanagi K, Sakai Y, Takabatake Y. Left ventricular diastolic dysfunction in coronary artery disease: effects of coronary revascularization. Clin Cardiol 1992; 15: 577-581
6 Inoue T, Sakai Y, Mrooka S, Takayanagi K, Hayashi T, Takabatake Y. Hemofiltration as treatment for patients with refractory heart failure. Clin Cardiol 1992; 15: 514-518
7 Inoue T, Morooka S, Sakai Y, Fujito T, Hoshi K, Asahi S, Takabatake Y. Oxygen demand-supply relationship in peripheral tissues as a therapeutic indicator in acute myocardial infarction with advanced heart failure. Cardiology 1993; 82: 30-35
8 Inoue T, Sakai Y, Morooka S, Hayashi T, Takayanagi K, Yamaguchi H, Takabatake Y. Venoarterial carbon dioxide tension gradient in acute heart failure. Cardiology 1993; 82: 383-387
9 Inoue T, Morooka S, Hayashi T, Takayanagi K, Sakai Y, Fujito T, Takabatake Y. Features of coronary artery lesions related to left ventricular aneurysm formation in anterior myocardial infarction. Angiology 1993; 44: 593-598
10 Inoue T, Sakai Y, Morooka S, Hayashi T, Takayanagi K, Yamanaka T, Kakoi H, Takabatake Y. Coronary flow reserve in patients with dilated cardiomyopathy. Am Heart J 1993; 125: 93-98
11 Inoue T, Sakai Y, Morooka S, Hayashi T, Takayanagi K, Yamaguchi H, Kakoi H, Takabatake Y. Vasodilatory capacity of coronary resistance vessels in dilated cardiomyopathy. Am Heart J 1994; 127: 376-381
12 Inoue T, Asahi S, Takayanagi K, Morooka S, Takabatake Y. QT Prolongation and possibility of ventricular arrhythmias after intracoronary papaverine. Cardiology 1994; 84: 9-13
13 Hoshi K, Inoue T, Kakoi H, Yamaguchi H, Sakai Y, Morooka S, Takabatake Y. Plasma thrombomodulin levels in coronary sinus blood in patients with coronary artery disease. Blood Coagul Fibrinolysis 1995; 6: 129-132
14 Kakoi H, Inoue T, Morooka S, Hayashi T, Takabatake Y. Relatioship between regional abnormality of left ventricular rapid filling and coronary microcirculation disturbance in hypertrophic cardiomyopathy. Clin Cardiol 1996; 19: 379-383
15 Inoue T, Fujito T, Hoshi K, Sakai Y, Yamaguchi H, Takayanagi K, Morooka S, Takabatake Y. A mechanism of ischemic preconditioning during percutaneous transluminal coronary angioplasty. Cardiology 1996; 87: 216-223
16 Inoue T, Fujito T, Hoshi K, Yamaguchi H, Sakai Y, Takayanagi K, Morooka S. Relatioship of thallium-201 clearance on exercise stress myocardial scintigraphy to coronary flow reserve in patients with coronary artery disease. Coron Artey Dis 1996; 7: 257-263
17 Inoue T, Sakai Y, Morooka S, Hayashi T, Takayanagi K, Takabatake Y. Expression of polymorphonuclear leukocyte adhesion molecules and its clinical significance in patients treated with percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1996; 28: 1127-1133
18 Inoue T, Hoshi K, Fujito T, Sakai Y, Morooka S, Sohma R. Early detection of platelet activation after coronary angioplasty. Coron Artery Dis 1996; 7: 529-534
19 Inoue T, Fujito T, Asahi S, Hoshi K, Sakai Y, Morooka S. Impaired left ventricular diastolic filling occurs in diabetic patients without atherosclerotic coronary artery disease. Am J Med Sci 1997; 313: 125-130
20 Inoue T, Hoshi K, Mizoguchi K, Shimizu M, Sakai Y, Morooka S. Cutting balloon angioplasty for restenosis lesion at distal anastomosis of saphenous vein graft. J Interven Cardiol 1997; 10: 121-124
21 Kamishirado H, Inoue T, Fujito T, Kase M, Shimizu M, Sakai Y, Takayanagi K, Morooka S, Natsui S. Effect of enalapril maleate on cerebral blood flow in patients with chronic heart failure. Angiology 1997; 48: 707-713
22 Inoue T, Kamishirado H, Ishiyama E, Hayashi T, Morooka S. Fulminant hepatic failure due to cardiac tamponade associated with mixed connective tissue disease. J Med 1997; 28: 129-135
23 Inoue T, Sakai Y, Fujito T, Hoshi K, Hayashi T, Takayanagi K, Morooka S. Clinical significance of neutrophil adhesion molecules expression after coronary angioplasty on the development of restenosis. Thromb Haemost 1998; 79: 54-58
24 Inoue T, Hoshi K, Matsunaga R, Yaguchi I, Morooka S, Shimizu M. Spiral coronary artery dissection complicating diagnostic coronary angiography: repair with multiple stent implantations. J Interven Cardiol 1998; 11: 61-65
25 Inoue T, Sakai Y, Hoshi K, Yaguchi I, Fujito T, Morooka S. Lower expression of neutrophil adhesion molecule indicates less vessel wall injury and might explain lower restenosis rate after Cutting Balloon angioplasty. Circulation 1998; 97: 2511-2518
26 Inoue T, Fujito T, Hoshi K, Sakai Y, Morooka S, Sohma R. Detection of platelets activated during acetylcholine-induced coronary vasospasm. Thromb Haemost 1998; 79: 1004-1007
27 Inoue T, Saniabadi AR, Matsunaga R, Hoshi K, Yaguchi I, Morooka S. Impaired endothelium-dependent acetylcholine-induced coronary artery relaxation in patients with high serum remnant lipoprotein particles. Atherosclerosis 1998; 139: 363-367
28 Inoue T, Asahi S, Tanaka K, Sakai Y, Morooka S. Three-dementional spiral CT angiography in renal artery stenosis. J Cardiovasc Diag P 1998; 15: 55-58
29 Inoue T, Sohma R, Morooka S. Cilostazol inhibit the expression of activation dependent membrane surface glycoprotein on the surface of platelets stimulated in-vitro. Thromb Res 1999; 93: 137-143
30 Inoue T, Matsunaga R, Morooka S, Uehara Y. Serum N-acetyl--glucosaminidase activity increases in association with insulin resistance in patients with coronary artery disease. Atherosclerosis 1999; 149: 117-122
31 Inoue T, Hoshi K, Yaguchi I, Iwasaki Y, Tanaka K, Takayanagi K, Morooka S. Serum levels of circulating adhesion molecules after coronary angioplasty. Cardiology 1999; 91: 236-242
32 Kamishirado H, Inoue T, Sakai Y, Matsunaga R, Morooka S. Six year survival of unoperated ventricular septal rupture following myocardial Infarction. Tex Heart Inst J 1999; 26: 315-317
33 Inoue T, Matsunaga R, Yaguchi I, Takayanagi K, Morooka S. Insulin resistance affects. endothelium-dependent acetylcholine-induced coronary artery response. Eur Heart J 2000; 21: 895-900
34 Inoue T, Yaguchi I, Mizoguchi K, Hoshi K, Takayanagi K, Morooka S, Saito S. Air embolism in the right coronary artery occurring during the left coronary angioplasty using the guiding catheter with a side hole. Catheter Cardiovasc Interv 2000; 49: 331-334
35 Inoue T, Hoshi K, Yaguchi I, Miyake Y, Shimizu M, Takayanagi K, Morooka S. Cutting Balloon angioplasty for ostial lesions of the left anterior descending artery. J Interven Cardiol 2000; 13: 7-14.
36 Inoue T. Air embolism in the right coronary artery occurring during the left coronary angioplasty using the guiding catheter with a side hole (reply). Catheter Cardiovasc Interv 2000; 50: 510-512
37 Inoue T, Sohma R, Miyazaki T, Iwasaki Y, Yaguchi I, Morooka S. Comparison of activation process of platelets and neutrophils after coronary stent implantation-vs-balloon angioplasty for stable angina pectoris. Am J Cardiol 2000; 86: 1057-1062
38 Inoue T, Yaguchi I, Mizoguchi K, Iwasaki Y, Takayanagi K, Morooka S, Asano S. Reflex sympathetic dystrophy following transbrachial cardiac catheterization. J Invas Cardiol 2000; 12: 481-483.
39 Inoue T, Takayanagi K, Morooka S, Uehara Y, Oda H, Seiki K, Nakajima H, Urade Y. Serum prostagrandin D synthase level after coronary angioplasty may predict occurrence of restenosis. Thromb Haemost 2001; 85: 165-170
40 Inoue T, Uchida T, Kamishirado H, Takayanagi K, Hayashi T, Morooka S. Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease. J Am Coll Cardiol 2001; 37: 775-779
41 Inoue T, Inoue K, Maeda H, Takayanagi K, Morooka S. Immunological response to oxidized LDL occurs in association with oxidative DNA damage independently of serum LDL levels in dyslipidemic patient. Clin Chim Acta 2001; 305: 115-121
42 Inoue T, Uchida T, Kamishirado H, Takayanagi K, Morooka S. Antibody against oxidized low density lipoprotein may predict progression or regression of atherosclerotic coronary artery disease. J Am Coll Cardiol 2001; 37: 1871-1876
43 Inoue T, Hayashi M, Uchida T, Takayanagi K, Hayashi T, Morooka S. Significance of platelet aggregability immediately after blood sampling and effect of cigarette smoking. Platelets 2001; 12: 415-418
44 Uchida T, Inoue T, Kamishirado H, Nakata T, Sakai Y, Takayanagi K, Morooka S. Unusual coronary artery aneurysm and acute myocardial infarction in a middle-aged man with systemic lupus erythematosus. Am J Med Sci 2001; 322: 163-165
45 Inoue T, Takayanagi K, Sakai Y, Hayashi T, Morooka S. Cardiac pacing as emergency care for serious bradyarrhythmia with circulatory shock. J Med 2001; 32: 321-331
46 Inoue T, Hayashi M, Takayanagi K, Morooka S. Lipid-lowering therapy with fluvastatin inhibits oxidative modification of low density lipoprotein and improves vascular endothelial function in hypercholesterolemic patients. Atherosclerosis 2002; 160: 369-376
47 Inoue T, Ichihara M, Uchida T, Sakai Y, Hayashi T, Morooka S. Three dimensional computed tomography showing partial anomalous pulmonary venous connection complicated by the Scimitar syndrome. Circulation 2002; 105: 663
48 Miyake Y, Inoue T, Morooka S, Ando H, Shimizu M. A novel methods for angioplasty of the left internal thoracic artery from a right arm approach using a YUMIKO-LITA catheter. Am J Cardiol 2002; 89: 984-986
49 Inoue T, Sakuma M, Yaguchi I, Mizoguchi K, Uchida T, Takayanagi K, Hayashi T, Morooka S. Early recanalization and plasma brain natriuretic peptide as an indicator of left ventricular function after acute myocardial infarction. Am Heart J 2002; 143: 790-796
50 Inoue T, Yaguchi I, Takayanagi K, Hayashi T, Morooka S, Eguchi Y. A new thrombolytic agent, monteplase, is independent of the plasminogen activator inhibitor in patients with acute myocardial infarction –initial results of the Combining Monteplase with angioplasty (COMA) trial-. Am Heart J 2002; 144: E5
51 Inoue T, Uchida T, Kamishirado H, Sakuma M, Sakai Y, Takayanagi K, Hayashi T, Morooka S. Possible relationship between insulin resistance and remnant-like lipoprotein particles on coronary endothelial dysfunction. Clin Cardiol 2002; 25: 532-536
52 Kamishirado H, Inoue T, Mizoguchi K, Uchida T, Nakata T, Sakuma M, Takayanagi K, Morooka S. Randomized comparison of Cilostazol vs. Ticlopidine for anti-platelet therapy after coronary stent implantation: for preventing late restenosis. Am Heart J 2002; 144: 303-308
53 Inoue T, Yaguchi I, Uchida T, Kamishirado H, Nakahara S, Sakai Y, Hayashi T, Morooka S. Clinical significance of the antibody against oxidized low density lipoprotein in acute myocardial infarction. Cardiology 2002; 98: 13-17
54 Kamishirado H, Inoue T, Sakuma M, Uchida T, Tsuda S, Takayanagi K, Hayashi T, Morooka S. The influence of diabetes mellitus on late clinical outcomes following coronary stent implantation. Int J Cardiol 2002; 84: 41-45
55 Inoue T, Takayanagi K, Hayashi T, Morooka S. Fluvastatin attenuate nitrate tolerance in patients with ischemic heart disease. Int J Cardiol 2003; 90: 181-188
56 Inoue T, Uchida T, Yaguchi I, Sakai Y, Takayanagi K, Morooka S. Stent-induced expression and activation of the leukocyte integrin Mac-1 is associated with neointimal thickening and restenosis. Circulation 2003; 107: 1757-1763
57 Inoue T, Yaguchi I, Mizoguchi K, Uchida T, Takayanagi K, Hayashi T, Morooka S, Eguchi Y. Accelerated plasminogen activator inhibitor may protect late restenosis after coronary stenting in acute myocardial infarction. Clin Cardiol 2003; 26: 153-157
58 Inoue T, Hayashi M, Takayanagi K, Morooka S. Oxidative DNA damage is induced by chronic cigarette smoking, but repaired by abstention. J Health Sci 2003; 29: 217-220
59 Uchida T, Inoue T, Kamishirado H, Takayanagi K, Morooka S. Prediction of short-term progression or regression of atherosclerotic coronary artery disease by lipoprotein (a) -a quantitative coronary angiographic study-. Angiology 2003; 54: 641-646
60 Inoue T, Kato T, Takayanagi K, Uchida T, Yaguchi I, Kamishirado H, Morooka S, Yoshimoto N. Circulating matrix metalloproteinase-1 and-3 in patients with acute coronary syndrome. Am J Cardiol 2003; 92: 1461-1464
61 Inoue T, Uchida T, Kamishirado H, Takayanagi K, Hayashi T, Morooka S, Saniabadi A, Nakajima K. Remnant-like lipoprotein particles as risk factors for coronary artery disease in elderly patients. Horm Metab Res 2004; 36: 298-302
62 Inoue T, Uchida T, Sakuma M, Imoto Y, Ozeki Y, Ozaki Y, Hikichi Y, Node K. Cilostazol Inhibits leukocyte integrin Mac-1, leading to a potential reduction in restenosis after coronary stent implantation. J Am Coll Cardiol 2004; 44: 1408-1414
63 Inoue T. Insulin resistance and coronary endothelial function: preface. Curr Drug Targets Cardiovasc Haematol Disord 2004; 4: i
64 Inoue T. Cigarette smoking as a risk factor of coronary artery disease and its effects on platelet function. Tobacco Induced Disease 2004; 2: 27-33
65 Inoue T, Hayashi M, Uchida T, Sakuma M, Hayashi T, Nakajima K, Node K. Difference in the influence of the lipid profile as a coronary risk factor in patients with and without diabetes mellitus. Vasc Dis Prevent 2005; 2: 11-16
66 Inoue T, Nishiki R, Kageyama M, Chida R, Hayashi T, Takayanagi K, Hikichi Y, Node K. Long-term benefits of monteplase prior to coronary angioplasty in acute myocardial infarction. Am J Cardiol 2005; 95: 506-508
67 Inoue T, Kato T, Uchida T, Sakuma M, Nakajima A, Shibazaki M, Imoto Y, Hikichi Y, Node K. Local release of C-reactive protein from the vulnerable plaque or coronary arterial wall injured by stenting. J Am Coll Cardiol 2005; 46: 239-245
68 Inoue T, Nishiki R, Kageyama M. Therapeutic potential of monteplase in acute myocardial infarction. Am J Cardiovasc Drugs 2005; 5: 225-231
69 Inoue T, Nishiki R, Kageyama M, Node K. Therapeutic potential of monteplase in acute myocardial infarction -as a powerful thromboltic agent prior to coronary intervention-. Cardiovasc Drug Rev 2005; 22: 320-333
70 Inoue T, Kato T, Uchida T, Sakuma M, Nakajima, A, Shibazaki M, Imoto Y, Hikichi Y, Node K. Local release of C-reactive protein from the vulnerable plaque or coronary arterial wall injured by stenting (reply). J Am Coll Cardiol 2006; 47: 1734
71 Inoue T, Kato T, Hikichi Y, Hashimoto S, Hirase T, Morooka T, Imoto Y, Takeda Y, Sendo F, Node K. Stent-induced neutrophil activation is associated with an oxidative burst in the inflammatory process, leading to neointimal thickening. Thromb Haemost 2006; 95: 43-48
72 Inoue T, Hikichi Y, Kato T, Morooka T, Yoshida K, Fujimatsu D, Komoda H, Kameda M, Nonaka M, Hashimoto S, Node K. Comparison of changes in circulating platelet-derived microparticles and platelet surface P-selectin expression after coronary stent implantation. Platelets 2006; 17: 416-420
73 Ikeda H, Inoue T, Uemura S, Kaihara R, Tanaka H, Node K. Effects of candesartan on post-menopausal symptoms in middle-aged and elderly women with hypertension. Hypertens Res 2006; 29: 1007-1012
74 Inoue T, Node K. Vascular failure -a new clinical entity for vascular disease-. J Hypertens 2006; 24: 2121-2130
75 Inoue T, Sata M, Hikichi Y, Sohma R, Fukuda D, Uchida T, Shimizu M, Komoda H, Node K. Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis. Circulation 2007; 115: 553-561
76 Inoue T, Morooka T, Moroe K, Ikeda H, Node K. Effect of telmisartan on cholesterol levels in patients with hypertension. -Saga Telmisartan Aggressive Research (STAR)-. Horm Metab Res 2007; 39: 1-5
77 Kamishirado H, Inoue T, Sakuma M, Tsuda T, Hayashi T, Takayanagi K, Node K. Effects of statins on restenosis after coronary stent implantation. Angiology 2007; 58: 55-60
78 Inoue T, Kotooka N, Morooka T, Komoda H, Uchida T, Aso Y, Inukai T, Okuno T, Node K. High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease. Am J Cardiol 2007; 100: 569-574
79 Nakamura T, Inoue T, Sugaya T, Kawagoe Y, Suzuki T, Ueda Y, Koide H, Node K. Beneficial effects of olmesartan and temocapril on urinary liver-type fatty acid binding protein levels in normotensive patients with IgA nephropathy. Am J Hypertens 2007; 20: 1195-1201
80 Inoue T, Node K. Statin therapy for vascular failure. Cardiovasc Drug Ther 2007; 21: 281-295
81 Inoue T, Komoda H, Kotooka N, Morooka T, Fujimatsu D, Hikichi Y, Soma R, Uchida T, Node K. Increased circulating platelet-derived microparticles are associated with stent-induced vascular inflammation. Atherosclerosis 2008; 196: 469-476
82 Kotooka N, Inoue T, Fujimatsu D, Morooka T, Hashimoto S, Hikichi Y, Uchida T, Sugiyama A, Node K. Pentraxin3 is a novel marker for stent-induced inflammation and neointimal thickening. Atherosclerosis 2008; 197: 368-374
83 Inoue T, Komoda H, Nonaka M, Kameda M, Uchida T, Node K. Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery disease. Int J Cardiol 2008; 124: 319-325
84 Kotooka N, Inoue T, Aoki S, Anan M, Komoda H, Node K. Prognostic value of pentraxin 3 in patients with chronic heart failure. Int J Cardiol 2008; 130: 19-22
85 Yoshida K, Inoue T, Hirakawa N, Node K. Endoscopic thoracic sympathectomy as a novel strategy for vasospastic angina refractory to medical treatment. J Cardiol 2008; 52: 49-52
86 Inoue T, Komoda H, Uchida T, Node K. Tropical fruit camu-camu (myrciaria dubia) has anti-oxidative and anti-inflammatory properties. J Cardiol 2008; 52: 127-132
87 Inoue T, Node K. Telmisartan as a metabolic sartan for targeting vascular failure. Expert Opin Pharmacother 2008; 9: 1397-1406
88 Inoue T, Eguchi Y, Matsumoto T, Kijima Y, Kato Y, Ozaki Y, Waseda K, Oda H, Seiki K, Node K, Urade Y. Lipocalin-type prostaglandin D synthase is a powerful biomarker for severity of stable coronary artery disease. Atherosclerosis 2008; 201: 385-391
89 Inoue T, Matsuoka H, Higashi Y, Ueda S, Sata M, Shimada K, Ishibashi Y, Node K. Flow-mediated vasodilation as a diagnostic modality for vascular failure. Hypertens Res 2008; 31: 2105-2113
90 Inoue T, Node K. Molecular basis of restenosis and novel issues of drug-eluting stents. Circ J 2009; 73: 615-621
91 Matsuo K, Inoue T, Node K. Estimated glomerular filtration rate as a predictor of secondary outcomes in Japanese patients with coronary artery disease. J Cardiol 2009; 53: 232-239
92 Node K, Inoue T, Boyko V, Goldberg I, Fisman EZ, Adler Y, Schwammenthal E, Matas Z, Behar S, Tenenbaum A. Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impairment. Cardiovasc Diabetol 2009; 8: 5
93 Inoue T, Taguchi I, Abe S, Li G, Hu R, Nakajima T, Hara A, Aoyama T, Kannagi R, Kyogashima M, Node K. Sulfatides are associated with neointimal thickning after vascular injury. Atherosclerosis 2010; 211: 291-296
94 Taguchi I, Inoue T, Kikuchi M, Toyoda S, Arikawa T, Abe S, Node K. Pleiotropic effects of angiotensin receptor blockers on dyslipidemia. Curr Vasc Pharmacol 2011; 9: 129-135
95 Inoue T, Taguchi I, Abe S, Toyoda S, Nakajima K, Sakuma M, Node K. Activation of matrix metalloproteinase-9 is associated with mobilization of bone marrow-derived cells after coronary stent implantation. Int J Cardiol 2011; 152: 332-336.
96 Inoue T, Taguchi I, Abe S, Toyoda S, Sakuma M, Node K. Inhibition of intestinal cholesterol absorption might explain cholesterol lowering effect of telmisartan. J Clin Pharm Ther 2011; 36: 103-110
97 Inoue T, Ikeda H, Nakamura T, Abe S, Taguchi I, Kikuchi M, Toyoda S, Miyazono M, Kishi T, Sanai T, Node K. Potential benefit of statin therapy for dyslipidemia with chronic kidney disease-Fluvastatin Renal Evaluation Trial (FRET)-. Intern Med 2011; 50: 1273-1278
98 Inoue T, Croce K, Morooka T, Sakuma M, Node K, Simon DI. Vascular inflammation and repair: implication for reendothelialization, restenosis, and stent thrombosis. JACC Cardiovasc Interv 2011; 4: 1057-1066
99 Kamura A, Inoue T, Kuroki S, Ishida S, Iimori K, Kato T, Naito H, Tamesue S, Ikada H, Node K. Anti-hypertensive treatment using an angiotensin receptor blocker and a thiazide diuretic improves patients’ quality of life: Saga Challenge AntihyperTensive Study (S-CATS). Hypertens Res 2011; 34: 1288-1294
100 Sohma R, Inoue T, Abe S, Taguchi I, Kikuchi M, Toyoda S, Arikawa T, Hikichi Y, Sanada S, Asanuma H, Kitakaze M, Node K. Cardioprotective effects of low-dose statin combined with low-dose anigiotensin receptor blocker in rat myocardial infarction model. J Cardiol 2012; 59: 91-96
101 Abe S, Yoneda S, Kanaya T, Oda K, Nishino S, Kageyama M, Taguchi I, Masawa N, Inoue T. Pathological features of in-stent restenosis after sirolimus-eluting stent vs. bare metal stent placement. Cardiovasc Pathol 2012; 21: e19-e22
102 Yoneda S, Abe S, Taguchi I, Masawa N, Inoue K, Inoue T. Inflammation and impaired wound healing after zotarolimus-eluting stent implantation. Cardiovasc Pathol 2012; 21: 511-514
103 Taguchi I, Oda K, Yoneda S, Kageyama M, Kanaya T, Toyoda S, Abe S, Node K, Inoue T. Evaluation of serial changes in tissue characteristics during statin-induced plaque regression using virtual histology-intravascular ultrasound studies. Am J Cardiol 2013; 111: 1246-1252
104 Taguchi I, Toyoda S, Takano K, Arikawa T, Kikuchi M, Ogawa M, Abe S, Node K, Inoue T. Irbesartan, an angiotensin receptor blocker, exhibits metabolic, anti-inflammatory and antioxidative effects in patients with high-risk hypertension. Hypertens Res 2013; 36: 608-613
105 Yoneda S, Abe S, Kanaya T, Oda K, Nishino S, Kageyama M, Taguchi I, Masawa N, Inoue T. Late phase inflammatory response as a feature of in-stent restenosis after drug-eluting stent implantation. Coron Artery Dis 2013; 24: 368-373
106 Amano H, Toyoda S, Arikawa T, Inami S, Otani N, Nishi Y, Kitagawa Y, Taguchi I, Abe S, Inoue T. Left ventricular function in pulmonary hypertension. Heart Vessels 2013; 28: 505-509
107 Taguchi I, Toyoda S, Arikawa T, Ogino Y, Koizumi S, Kikuchi M, Abe S, Node K, Inoue T. Is direct rennin inhibition superior to angiotensin receptor blockade in the effects beyond blood pressure lowering? Jpn J Clin Physiol 2013; 43: 89-95
108 Tokura M, Taguchi I, Kageyama M, Nasuno T, Nishiyama Y, Koshiji N, Koizumi S, Uehara D, Ogino Y, Toyoda S, Abe S, Inoue T. Clinical features of spontaneous coronary artery dissection. J Cardiol 2014; 63: 119-122
109 Kitagawa Y, Abe S, Toyoda S, Watanabe S, Ebisawa K, Murakami Y, Takahashi T, Sugimura H, Taguchi I, Inoue T. Gender differences in the ratio of eicosapentaenoic acid to arachidonic acid in an inland prefecture, Tochigi: Tochigi Ryomo EPA/AA trial in coronary artery disease (TREAT-CAD). Intern Med 2014; 53: 177-182
110 Taguchi I, Yoneda S, Abe S, Toyoda S, Nasuno T, Nishino S, Kageyama M, Tokura M, Ogawa M, Node K, Inoue T. The late phase inflammatory response after drug-eluting stent implantation. Heart Vessels 2014; 29: 213-219
111 Taguchi I, Kageyama M, Kanaya T, Abe S, Node K, Inoue T. Clinical significance of non-slip element balloon angioplasty for patients of coronary artery disease: a preliminary report. J Cardiol 2014; 63: 19-23
112 Taguchi I, Koizumi S, Kageyama M, Nasuno T, Toyoda S, Abe S, Node K, Inoue T. Risk markers for coronary plaque progression and destabilization beyond LDL-cholesterol in acute coronary syndrome. Int J Cardiol 2014; 173: 329-331
113 Toyoda S, Kikuchi M, Komatsu T, Hori Y, Nakahara S, Kobayashi S, Sakai Y, Inoue T, Taguchi I. Impact of the oral adsorbent AST-120 on oxidative stress and uremic toxins in high-risk chronic kidney disease patients. Int J Cardiol 2014; 177: 705-707
114 Toyoda S, Tajima E, Fukuda R, Inami S, Amano H, Arikawa T, Yoshida A, Hishinuma A, Inoue T. Early surgical intervention and optimal medical treatment for Candida parapsilosis endocarditis. Intern Med 2015; 54: 411-413
115 Toyoda S, Inami S, Kato T, Tsukada K, Nakamoto A, Kikegawa Y, Suzuki A, Anraku Y, Node K, Inoue T. Choice of anti-hypertensive combination therapy based on daily salt intake. Am J Med Sci 2015; 350: 160-166
116 Toyoda S, Inami S, Masawa T, Shibasaki I, Yamada Y, Fukuda H, Kubo T, Nakajima N, Kato H, Inoue T. Hypopharyngeal perforation caused by intraoperative transesophageal echocardiography. J Med Ultrason 2015; 57: 247-250
117 Inoue T. Ischemia-reperfusion injury is still a big hurdle to overcome for treatment of acute myocardial infarction. J Cardiol 2016; 67: 305-306
118 Arikawa T, Toyoda S, Haruyama A, Amano H, Inami S, Otani N, Sakuma M, Taguchi I, Abe S, Node K, Inoue T. Impact of obstructive sleep apnea on heart failure with preserved ejection fraction. Heart Lung Circ 2016; 25: 435-441.
119 Iwamatsu K, Abe S, Kageyama M, Nasuno T, Sakuma M, Toyoda S, Inoue T. Which has the stronger impact on coronary artery disease, eicosapentaenoic acid or docosahexaenoic acid? Hypertens Res 2016; 39: 272-275.
120 Kishimoto S, Inoue K, Nakamura S, Hattori H, Ishihara M, Sakuma M, Toyoda S, Iwaguro H, Taguchi I, Inoue T, Yoshida K. Atherosclerosis 2016; 249: 132-139
121 Nasuno T, Kageyama M, Toyoda S, Sakuma M, Komatsu T, Taguchi I, Abe S, Inoue T. The wound healing response after implantation of a drug-eluting stent is impaired persistently in the long-term. Heart Vessels 2016; 31: 985-989
122 Masawa T, Abe S, ToyodaS, Sakuma M, Nasuno,T, Kageyama M, Tokura M, Koizumi S, Taguchi I, Inoue T. Comparison of the performance of zotarolimus- and everolimus-eluting stents by optical coherence tomography and coronary angioscopy. Heart Vessels 2016; 31: 1230-1238
123 Yamauchi F, Adachi H, Tomono J, Toyoda S, Iwamatsu K, Sakuma M, Nakajima T, Oshima S, Inoue T. Effect of a cardiac rehabilitation program on exercise oscillatory ventilation in Japanese patients with heart failure. Heart Vessels 2016; 31: 1659-1668
124 Kageyama M, Yamauchi F, Masawa T, Nasuno T, Sakuma M, Abe S, Inoue T. Percutaneous coronary intervention for spontaneous coronary artery dissection under intravascular ultrasound guidance. Int J Cardiovasc Res 2016; 5: 2.
125 Toyoda S, Haruyama A, Inami S, Amano H, Arikawa T, Sakuma M, Abe S, Tanaka A, Node K, Inoue T. Protective effects of bisoprolol against myocardial injury and pulmonary dysfunction in patients with chronic heart failure. Int J Cardiol 2017; 226: 71-76
126 Obi S, Nakajima T, Hasegawa T, Kikuchi H, Oguri G, Takahashi M, Nakamura F, Yamasoba T, Sakuma M, Toyoda S, Tei C, Inoue T. Heat induces interleukin-6 in skeletal muscle cells via TRPV1/PKC/CREB pathways. J Appl Physiol 2017; 122: 683-694
127 Kageyama M, Abe S, Iwamatsu k, Nishida H, Koizumi S, Nasuno T, Yoneda S, Sakuma M, Inoue T. The different features of angiographic peri-stent contrast staining after implantation of sirolimus-eluting stents. Clin Case Rep 2017; 5: 333-337
128 Tajima E, Abe S, Watanabe R, Koyabu R, Saito F, Kaneda H, Sakuma M, Toyoda S, Inoue T. Effects of purified eicosapentaenoic acid on red blood cell distribution width and vascular endothelial function in patients with coronary artery disease. Vasc Fail 2017; 1: 15-21
129 Tada N, Haga Y, Suzuki S, Enta Y, Miyasaka M, Inoue H, Taguri M, Ishii K, Hata M, Sakuma M, Toyoda S, Inoue T, Ootomo T. Computed tomographys core of aortic valve tissue might predict cerebral embolism during transcatheter aortic valve implantation. JACC Cardiovasc Imaging 2017; 10: 960-962
130 Amano H, Abe S, Hirose S, Waku R, Masuyama T, Sakuma M, Toyoda s, Taguchi I, Inoue T, Tei C. Comparison of echocardiographic parameters to assess right ventricular function in pulmonary hypertension. Heart Vessels 2017; 32: 1214-1219
131 Sakuma M, Tanaka A, Kotooka N, Hikichi Y, Toyoda S, Abe S, Taguchi I, Node K, Simon DI, Inoue T. Myeloid-related protein-8/14 in acute coronary syndrome. Int J Cardiol 2017; 249: 25-31

続きを見る

井上 晃男先生 の所属する医療機関

獨協医科大学病院

TEL: 0282-86-1111

獨協医科大学病院

栃木県下都賀郡壬生町北小林880

東武鉄道宇都宮線「おもちゃのまち」駅 徒歩10分

- -

受付時間: 8:00〜11:00 原則紹介制、一部診療科予約制 診療は9:00開始 科により異なる 第3土曜、開学記念日(4/23)休診 臨時休診あり

診療科目: 内科 アレルギー科 血液内科 リウマチ科 外科 精神科 神経内科 脳神経外科 呼吸器外科 腎臓内科 心臓血管外科 小児科 小児外科 整形外科 形成外科 美容外科 皮膚科 泌尿器科 産婦人科 眼科 耳鼻咽喉科 リハビリテーション科 放射線科 歯科口腔外科 麻酔科 乳腺外科

院長インタビュー